- Home
- COYA vs MODV Comparison
COYA vs MODV Comparison
Compare COYA & MODV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- MODV
- Stock Information
- Founded
- COYA 2020
- MODV 1996
- Country
- COYA United States
- MODV United States
- Employees
- COYA N/A
- MODV N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- MODV Transportation Services
- Sector
- COYA Health Care
- MODV Consumer Discretionary
- Exchange
- COYA Nasdaq
- MODV Nasdaq
- Market Cap
- COYA 98.5M
- MODV 81.8M
- IPO Year
- COYA 2022
- MODV N/A
- Fundamental
- Price
- COYA $6.41
- MODV $5.05
- Analyst Decision
- COYA Strong Buy
- MODV Buy
- Analyst Count
- COYA 4
- MODV 5
- Target Price
- COYA $16.25
- MODV $18.20
- AVG Volume (30 Days)
- COYA 92.0K
- MODV 634.6K
- Earning Date
- COYA 03-18-2025
- MODV 03-04-2025
- Dividend Yield
- COYA N/A
- MODV N/A
- EPS Growth
- COYA N/A
- MODV N/A
- EPS
- COYA N/A
- MODV N/A
- Revenue
- COYA $9,554,315.00
- MODV $2,787,619,000.00
- Revenue This Year
- COYA N/A
- MODV $3.37
- Revenue Next Year
- COYA $56.22
- MODV $2.71
- P/E Ratio
- COYA N/A
- MODV N/A
- Revenue Growth
- COYA N/A
- MODV 3.16
- 52 Week Low
- COYA $4.75
- MODV $3.64
- 52 Week High
- COYA $10.69
- MODV $39.48
- Technical
- Relative Strength Index (RSI)
- COYA 52.07
- MODV 38.32
- Support Level
- COYA $5.85
- MODV $5.73
- Resistance Level
- COYA $7.25
- MODV $6.09
- Average True Range (ATR)
- COYA 0.51
- MODV 0.60
- MACD
- COYA -0.04
- MODV 0.35
- Stochastic Oscillator
- COYA 32.94
- MODV 54.23
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.